Governance Novartis AG

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 16:30:59 12/03/2026 GMT			5-day change	1st Jan Change
120.84 ^CHF	-0.33%		-3.19%	+10.26%

03:11pm	Viatris settles lawsuit over use of woman's 'immortal' cells to power drug research	RE
10:23am	Mesoblast Limited Appoints Dr. Teresa Montagut As Head Of Clinical Development And Medical Affairs	CI

Executive Committee: Novartis AG

Manager

Positions heldSince

Vasant Narasimhan

50 year

Chief Executive Officer

31/01/2018

Charlotte Pamer-Wieser

52 year

Corporate Secretary

31/08/2011

Shreeram Aradhye

64 year

Chief Tech/Sci/R&D Officer

15/05/2022

Teresa Jose

58 year

Comptroller/Controller/Auditor

30/06/2025

Robert Kowalski

58 year

Human Resources Officer

31/08/2021

Harry Werner Kirsch

61 year

Director of Finance/CFO

23/04/2013

Karen Hale

58 year

Compliance Officer	13/04/2025
General Counsel	14/05/2021

Steffen Lang

59 year

Chief Operating Officer

03/04/2022

Composition of the Board of Directors: Novartis AG

Director

CommitteesSince

Giovanni Caforio

62 year

Compensation Committee
HR Committee
Governance Committee
Nominating Committee

Bridgette Heller

65 year

Compensation Committee Chair	12/09/2019
Audit Committee	27/02/2020
Compensation Committee	27/02/2020
Governance Committee	01/02/2021
Nominating Committee	01/02/2021
Finance Committee

Frans van Houten

65 year

Audit Committee
Governance Committee	06/03/2025
Nominating Committee	06/03/2025
Governance Committee Chair
Nominating Committee Chair

Nancy Andrews

68 year

Governance Committee Chair	19/05/2025
Nominating Committee Chair	19/05/2025
Compensation Committee	31/01/2021

Patrice Bula

70 year

Compensation Committee	27/02/2019
Governance Committee Chair	27/02/2019
Nominating Committee Chair	27/02/2019

Simon Moroney

67 year

Compensation Committee Chair	27/02/2020
Compensation Committee	31/03/2021
Nominating Committee	31/03/2021

Ana de Pro Gonzalo

59 year

Audit Committee	03/03/2022
Compensation Committee	03/12/2021
Audit Committee Chair	31/05/2020

John Young

62 year

Compensation Committee Chair
Governance Committee
Compensation Committee	06/03/2025

Liz Doherty Doherty

69 year

Audit Committee Chair

09/05/2019

Ton Büchner

61 year

Audit Committee

01/03/2018

Elizabeth McNally

65 year

Director/Board Member	06/03/2025
Independent Dir/Board Member	06/03/2025

Charles Swanton

54 year

Director/Board Member

05/03/2026

Latest Appointments: Novartis AG

10:23am	Mesoblast Limited Appoints Dr. Teresa Montagut As Head Of Clinical Development And Medical Affairs	CI
03-06	Novartis Shareholders Approve Dividend Raise, Share Capital Reduction	MT
03-06	Novartis AG Approves Board and Committee Appointments	CI
03-06	Novartis Shareholders Re-elect Board Chair	MT
02-26	Propanc Biopharma, Inc. Announces Board Changes, Effective February 20, 2026	CI
02-24	Adocia SA Announces Board Changes	CI
02-23	Tectonic Therapeutic, Inc. Announces Board and Committees Changes	CI

More news

Former Officers and Directors: Novartis AG

Insider

Positions held

SinceUntil

Srikant T. Madhav Datar

Director/Board Member	31/12/2002	31/12/2020
Independent Dir/Board Member	31/12/2002	31/12/2020

Pierre Landolt

Director/Board Member	07/01/2010	01/03/2018
Independent Dir/Board Member	07/01/2010	01/03/2018
Corporate Officer/Principal	31/12/1995	07/01/2010

Joseph Jimenez

Director/Board Member	01/11/2009	07/01/2010
Chief Executive Officer	31/01/2010	31/12/2017
Corporate Officer/Principal	07/01/2010	25/01/2010

Jürgen Brokatzky-Geiger

Human Resources Officer	31/12/2004	05/03/2014
Corporate Officer/Principal	05/03/2014	30/09/2017

Wendelin Wiedeking

Director/Board Member	31/12/2002	24/02/2014
Independent Dir/Board Member	31/12/2002	24/02/2014
Corporate Officer/Principal	31/12/2002	07/01/2010

Rolf M. Zinkernagel

Director/Board Member	07/01/2010	24/02/2014
Independent Dir/Board Member	31/12/1998	24/02/2014
Corporate Officer/Principal	31/12/1998	07/01/2010

Alexandre F. Jetzer-Chung

Director/Board Member	07/01/2010	21/02/2011
Corporate Officer/Principal	31/12/1995	07/01/2010

Raymund Breu

Director of Finance/CFO

30/11/1996

31/12/2008

Hans Jörg Reinhardt

Chief Operating Officer	31/12/2007	31/12/2009
Corporate Officer/Principal	31/12/2005	31/12/2007
Chairman	31/12/2012	06/03/2025
Independent Dir/Board Member	31/12/2012	06/03/2025

William Brody

Director/Board Member	23/02/2009	-
Independent Dir/Board Member	24/08/2011	-

Urs Bärlocher

General Counsel

31/12/1998

30/08/2007

Thomas Ebeling

Corporate Officer/Principal

31/12/1999

31/12/2006

Karen Hübscher

Public Communications Contact

31/12/1999

31/12/2005

Andreas von Planta

Director/Board Member	31/12/2005	-
Independent Dir/Board Member	31/12/2005	-

Pierre F. Dodion

Sales & Marketing

31/12/2001

31/12/2005

François Martelet

Corporate Officer/Principal

30/06/2003

30/06/2005

Ian Garland

Corporate Officer/Principal

31/05/2005

Joachim P. H. Schupp

Corporate Officer/Principal

31/12/1984

30/09/2004

Ronen Tamir

Investor Relations Contact	27/10/2011	-
Public Communications Contact	27/10/2011	-
Corporate Officer/Principal	31/12/2003	27/10/2011

Marshall E. Reese

Corporate Officer/Principal

31/12/1998

31/12/2003

Mihael Polymeropoulos

Corporate Officer/Principal

31/12/1997

31/12/2002

Gilbert Wenzel

Corporate Officer/Principal

31/10/2000

31/12/2002

Paul Herrling

Chief Tech/Sci/R&D Officer

31/10/2002

Bruce F. Fleming

Corporate Officer/Principal

31/05/2001

31/05/2002

Silke Zentner

Public Communications Contact

04/04/2002

Fredrik Ollila

Corporate Officer/Principal

31/12/2001

Paolo Baroldi

Corporate Officer/Principal

31/12/1997

31/12/2001

James New

Corporate Officer/Principal

31/12/1998

Helmut Sihler

Director/Board Member

31/12/1995

Birgit Breuel

Corporate Officer/Principal

31/12/1995

Norman Hardman

Chief Tech/Sci/R&D Officer

31/12/1995

Peter Burckhardt

Director/Board Member	30/12/2009	-
Corporate Officer/Principal	31/12/1995	30/12/2009

John McKenna

Corporate Officer/Principal

31/12/1989

Ann Bailey

Public Communications Contact

31/12/1981

Gabor Veres

Corporate Officer/Principal

Siv Lindbratt Börjes

Corporate Officer/Principal

Adrian Hunter

Corporate Officer/Principal

MaryAnn DeMarco

Corporate Officer/Principal

David Metzger

Corporate Officer/Principal

Virginia Jamieson

Corporate Officer/Principal

Max Burger

Chairman	20/04/2010	-
President	16/07/2009	20/04/2010

Ian Stuart Charles Talmage

Corporate Officer/Principal

Michael Horne

Corporate Officer/Principal

John McAdoo

Corporate Officer/Principal

Ian Matthews

Corporate Officer/Principal

Geoff MacKay

Corporate Officer/Principal

Jutta Monika Heim

Corporate Officer/Principal

Peter Thomas Sany

Chief Tech/Sci/R&D Officer

William P. Keane

Corporate Officer/Principal

Nagesh Mahanthappa

Corporate Officer/Principal

Ann Moravick

Corporate Officer/Principal

Bobby Singh

Corporate Officer/Principal

Dominique Cheneval

Corporate Officer/Principal

John H. van Duzer

Corporate Officer/Principal

Randall S. Moore

Corporate Officer/Principal

Eric Wayne Evans

Director of Finance/CFO

Christoph Hüls

Corporate Officer/Principal

Ingrid Duplain

Corporate Secretary

Bruno Heynen

Corporate Secretary

Corinne Hoff

Public Communications Contact

Stuart J. Davie

Chief Tech/Sci/R&D Officer

Günter Frankenne

Director/Board Member

Karel Petrak

Corporate Officer/Principal

Peter E. Carlin

Corporate Officer/Principal

Terry Hart

Corporate Officer/Principal

Geert C. Mudde

Corporate Officer/Principal

Phil Johnson

Corporate Officer/Principal

Malcolm B. Cheetham

Comptroller/Controller/Auditor

James Phillips

Corporate Officer/Principal

Maike July-Grolman

Corporate Officer/Principal

Armin M. Kessler

Sales & Marketing

Hans-Georg Capraro

Corporate Officer/Principal

William J. Rutter

Director/Board Member

Gordon Wright

Corporate Officer/Principal

Jeret Bode

Corporate Officer/Principal

Rob Goshert

Corporate Officer/Principal

Jeffrey Hrkach

Corporate Officer/Principal

Peter Herold

Corporate Officer/Principal

Thomas Littke

Corporate Officer/Principal

John Slevin

Corporate Officer/Principal

Cees Winnips

Corporate Officer/Principal

Humphrey Harte

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	19
Female	7

Of which Executive Committee

Male	6
Female	2

Of which Directors

Male	9
Female	3

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).

Employees

75,267

Sector

Pharmaceuticals

Calendar

04-28 - Earnings release - Q1 2026

More about the company